drugset / Trial / NCT00943358
Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults
Phase 1
Completed
175 enrolled
University Hospitals, Leicester
Novartis Vaccines · collabPublic Health England · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the antibody response to one and two doses of influenza A/H1N1v vaccine in healthy adults.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MF59 H1N1 vaccine | Unknown | 3.75 ug | Intramuscular |
| Comparator | MF59 H1N1 vaccine | Unknown | 7.5 ug | Intramuscular |
| Comparator | Plain H1N1 vaccine | Vaccine | 7.5 ug | Intramuscular |
| Comparator | Plain H1N1 vaccine | Vaccine | 15 ug | Intramuscular |